^
Association details:
| Biomarker: | PTEN mutation |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | AZD6482 (PI3Kβ inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
PI3K pathway dependencies in endometrioid endometrial cancer cell lines
Excerpt:
PTEN-mutant EEC cell lines were resistant to the p110β inhibitors GSK2636771 and AZD6482, and only in combination with the p110α selective inhibitor A66, a decrease in cell viability was observed.... treatment with the p110β isoform-specific inhibitors GSK2636771, AZD6482 and TGX-221 or the p110α isoform-specific inhibitor A66 revealed that the EEC cell lines tested were resistant to these agents...
DOI:
10.1158/1078-0432.CCR-12-3815
